Syros

+$0.04 (+0.77%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Syros and other stocks, options, and ETFs commission-free!

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.

CEO
Nancy A. Simonian
Employees
103
Headquarters
Cambridge, Massachusetts
Founded
2011

SYRS Key Statistics

Market Cap
335.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
639.35K
High Today
$5.51
Low Today
$5.05
Open Price
$5.05
Volume
796.34K
52 Week High
$15.65
52 Week Low
$4.75

SYRS Earnings

-$0.62
-$0.49
-$0.36
-$0.23
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.46 per share
Actual
-$0.23 per share
Replay Earnings Call

You May Also Like

NRUC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure